FDA Watch: Zepto Life Technology Receives FDA Breakthrough Designation for Blood-Based Mold Test
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
From – National Intelligence Report
As if Year 2 of PAMA lab fees wasn’t enough, CMS dished out another dose of agita to the lab industry: CLIA fees will…
From – National Intelligence Report
If you’ve been in the clinical labs business for a while, you probably appreciate the wisdom behind this ancient Chinese curse. 2018 is shaping up to be a very…
From – National Intelligence Report
The FDA’s longstanding policy of restricting direct-to-consumer (DTC) marketing of products without formal premarket approval is well known. But while it always applied to…
From – National Intelligence Report
The CLIA standards that a lab must meet are based on the complexity of the in vitro diagnostic tests it…